Holen Sie sich die Stockscreener-App
5.14
7.31%
0.35
Handel nachbörslich:
5.27
0.13
+2.53%
Schlusskurs vom Vortag:
$4.79
Offen:
$5.15
24-Stunden-Volumen:
807.28K
Relative Volume:
0.84
Marktkapitalisierung:
$166.37M
Einnahmen:
$105.38M
Nettoeinkommen (Verlust:
$17.78M
KGV:
1.9251
EPS:
2.67
Netto-Cashflow:
$-50.48M
1W Leistung:
+3.21%
1M Leistung:
+91.08%
6M Leistung:
+88.97%
1J Leistung:
+51.18%
1-Tages-Spanne:
$4.97
$5.19
1-Wochen-Bereich:
$4.62
$5.5477
52-Wochen-Spanne:
$1.46
$9.00
Mei Pharma Inc Stock (MEIP) Company Profile
Firmenname
Mei Pharma Inc
Sektor
Branche
Telefon
858-369-7100
Adresse
11455 EL CAMINO REAL, SAN DIEGO, CA
Vergleichen Sie MEIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEIP
Mei Pharma Inc
|
5.14 | 155.04M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Herabstufung | Laidlaw | Buy → Hold |
| 2022-03-25 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-03-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-03 | Eingeleitet | Jefferies | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-29 | Eingeleitet | SunTrust | Buy |
| 2018-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-27 | Hochstufung | Stifel | Hold → Buy |
| 2018-07-13 | Eingeleitet | SunTrust | Buy |
| 2016-04-18 | Bestätigt | Wedbush | Neutral |
| 2015-03-23 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-18 | Bestätigt | ROTH Capital | Buy |
| 2014-10-16 | Bestätigt | ROTH Capital | Buy |
| 2014-07-08 | Fortgesetzt | Brean Capital | Buy |
| 2013-10-22 | Bestätigt | Stifel | Buy |
| 2013-04-15 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mei Pharma Inc Aktie (MEIP) Neueste Nachrichten
Measuring MEI Pharma Inc.’s beta against major indicesChart Signals & Comprehensive Market Scan Reports - Newser
Strategies to average down on MEI Pharma Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Pattern recognition hints at MEI Pharma Inc. upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Volume spikes in MEI Pharma Inc. stock – what they meanIndex Update & AI Enhanced Trading Alerts - Newser
How to manage a losing position in MEI Pharma Inc.Alpha Stock Picks with Chart Confirmation - Newser
Litecoin Surges 24% as MEI Pharma Boosts Treasury with $100M Investment - AInvest
Evaluating MEI Pharma Inc. with trendline analysisReal Time Stock Movement and Alerts - Newser
Is it too late to sell MEI Pharma Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Combining machine learning predictions for MEI Pharma Inc.AI Screener for Daily Stock Forecast - Newser
Litecoin Hits Five-Month High on ETF Hype and MEI Pharma Treasury Deal - AInvest
How to read the order book for MEI Pharma Inc.Buy Strategy Review With Performance Summary - Newser
Institutional scanner results for MEI Pharma Inc.Predictable Entry Strategy With Technical Backing - Newser
Will MEI Pharma Inc. stock benefit from AI tech trendsDaily Market Movers Screener with Filters - Newser
Chart overlay techniques for tracking MEI Pharma Inc.AI Short-Term Gain Forecast with Data - Newser
What Fibonacci levels say about MEI Pharma Inc. reboundConservative Investment Setup and Risk Analysis - Newser
How to monitor MEI Pharma Inc. with trend dashboardsAI Volatility Forecast and Risk Monitor - Newser
What’s the analyst consensus on MEI Pharma Inc.Trade Picks with 3x Upside - sisain.net
Technical analysis overview for MEI Pharma Inc. stockTrade Ideas Based on Fundamental Metrics - Newser
How to escape a deep drawdown in MEI Pharma Inc.Fast Return Equity Forecast With Logic - Newser
How MEI Pharma Inc. stock performs during market volatilityWeekly Trend Watch with Market Signals - Newser
Can MEI Pharma Inc. stock recover from recent declineTechnical Setup Guide for Daily Watchlist - Newser
MEI Pharma Welcomes New Board Member Joshua Riezman - TipRanks
Bitcoin News Today: MEI Pharma Invests $100M in Litecoin as Treasury Diversification Strategy - AInvest
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin in Bold Treasury Shift - AInvest
Can machine learning forecast MEI Pharma Inc. recoveryFree AI Driven Stock Trend Forecast - Newser
Litecoin Soars as MEI Pharma Launches $100M Institutional Treasury StrategyFinanceSecond - financesecond.com
MEI Pharma Kicks Off Its Litecoin-Focused Digital Asset Treasury with $110M Purchase - NFTgators
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired - Bitcoin.com News
Bitcoin News Today: MEI Pharma Allocates $100M to Litecoin as Core Treasury Asset - AInvest
MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset - Benzinga
MEI Pharma Launches $110 Million Litecoin Treasury Strategy - CoinCentral
MEI Pharma's Litecoin treasury purchase sets off LTC rally - Mitrade
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin as Primary Treasury Asset with GSR and Charlie Lee - AInvest
Litecoin Hits Five-Month High on ETF Optimism and $100M MEI Pharma Investment - AInvest
Litecoin Hits Five-Month High Amid ETF Optimism and $100M MEI Pharma Treasury - Yahoo Finance
Mei Pharma acquires Litecoin, launches $100m institutional treasury strategy - MarketScreener
MEI Pharma Acquires Litecoin as Primary Reserve Asset - TipRanks
MEI Pharma acquires $100 million in Litecoin for treasury strategy - Investing.com
MEI Pharma acquires $100 million in Litecoin for treasury strategy By Investing.com - Investing.com Nigeria
MEI Pharma Invests in Litecoin as Primary Treasury Asset - San Diego Business Journal
MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
US-listed MEI Pharma purchases Litecoin worth ₩110 billion - bloomingbit
Bollinger Band Squeeze Points to Volatility in MEI Pharma Inc.AI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Finanzdaten der Mei Pharma Inc-Aktie (MEIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):